6OOA
Human CYP3A4 bound to a drug substrate
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ALS BEAMLINE 5.0.2 |
| Synchrotron site | ALS |
| Beamline | 5.0.2 |
| Temperature [K] | 77 |
| Detector technology | PIXEL |
| Collection date | 2018-04-13 |
| Detector | DECTRIS PILATUS3 6M |
| Wavelength(s) | 1.0 |
| Spacegroup name | I 2 2 2 |
| Unit cell lengths | 76.499, 101.590, 125.529 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 65.325 - 2.520 |
| R-factor | 0.198 |
| Rwork | 0.195 |
| R-free | 0.25230 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 5vcc |
| RMSD bond length | 0.009 |
| RMSD bond angle | 1.159 |
| Data reduction software | iMOSFLM |
| Data scaling software | SCALA |
| Phasing software | PHASER |
| Refinement software | PHENIX ((1.11.1_2575)) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 78.970 | 2.660 |
| High resolution limit [Å] | 2.520 | 2.520 |
| Rmerge | 0.074 | 1.500 |
| Rpim | 0.034 | 0.691 |
| Number of reflections | 16915 | 2438 |
| <I/σ(I)> | 11.1 | 1.2 |
| Completeness [%] | 100.0 | 100 |
| Redundancy | 5.6 | 5.6 |
| CC(1/2) | 0.999 | 0.366 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 7 | 298 | PEG 3350 |






